1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NORD's Patient Assistance Programs (RareCare® Patient Assistance Programs) is sponsored by National Organization for Rare Disorders (NORD). NORD offers various assistance programs to help patients with rare diseases obtain life-saving or life-sustaining medication, financial assistance with insurance premiums and co-pays, diagnostic testing assistance, and travel assistance for clinical trials or consultations with …
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NORD’s Patient Assistance Program for Assistance With Phenylketonuria (PKU) - UIC Division of Specialized Care for Children You are using an outdated browser. Please upgrade your browser to improve your experience.
NORD’s Patient Assistance Program for Assistance With Phenylketonuria (PKU) NORD’s RareCare program is accepting applications from individuals with Phenylketonuria (PKU) who need help with medical expenses The National Organization for Rare Disorders (NORD) ‘s RareCare program is accepting applications for PKU emergency relief, PKU medical assistance and PKU premium copay assistance.
RareCare Patient Assistance Programs can help individuals living with rare diseases with: Receiving financial help with insurance premiums and copays Getting diagnostic testing assistance Connecting with other patient assistance programs For more information and to submit an application, visit NORD’s RareCare Patient Assistance Programs PKU page . You will need to enter your email and the patient’s date of birth.
You’ll receive a link to the enrollment application through the email address you provide. If you have questions, please contact NORD at (855) 628-0646. For help with emergency relief questions, please email NordERF@rarediseases.
org . Please email medical and premium copay assistance questions to pku@rarediseases. org .
According to the current listing, eligibility includes: Individuals living with rare diseases who are struggling to afford their medications and care. Specific eligibility criteria vary by program. Confirm the full requirements in the official notice before applying.
NORD's Patient Assistance Programs (RareCare® Patient Assistance Programs) is funded by National Organization for Rare Disorders (NORD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Anthropic is giving rare-disease researchers and early-stage biotechs up to $50,000 in Claude API credits over six months — not cash, but compute. Here is how the two-track program works, who is eligible, what the credits can and cannot do, and how it fits a fast-growing new category: the compute-as-grant model reshaping how AI-for-science actually gets funded.
Read articleThe Department of Energy's Office of Critical Minerals and Energy Innovation is spending to break America's 95% dependence on foreign rare earths. The strategy is unusual: recover critical materials from the waste streams of coal plants, smelters, and refineries that already exist. Here is the full funding architecture — the $75M just awarded, the $500M battery-materials round, the $1B pipeline behind them — and how an industrial operator should position for what comes next.
Read articleOn June 2, 2026, the Department of Energy's Office of Critical Minerals and Energy Innovation selected two demonstration-scale facilities — Phoenix Tailings (with MIT and the University of Minnesota) for $66 million, and the Colorado School of Mines (with ElementUSA, PNNL, Principal Mineral, and Rare Earth Technologies Inc.) for the balance — under the Rare Earth Elements Demonstration Facility Program. Both projects pull rare earths from industrial waste — red mud at the Gramercy refinery in Louisiana, and a mix of mine and refining tailings elsewhere. Here is what the selections tell researchers, small businesses, and downstream magnet customers about where DOE thinks the chokepoint actually is, and what to do before the next demonstration-scale solicitation opens.
Read article